Australia Stock Exchange release from ORTHOCELL : Appendix 4C - Quarterly
31/01/2022 06:48
Australia Stock Exchange release from ORTHOCELL OCC.AX : Appendix 4C - Quarterly
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense